Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism.
MicroRNAs
cancer
immune cell
immunometabolism
metabolism
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
12
09
2022
accepted:
24
10
2022
entrez:
9
12
2022
pubmed:
10
12
2022
medline:
10
12
2022
Statut:
epublish
Résumé
MicroRNAs (miRNAs) are emerging as a significant modulator of immunity, and their abnormal expression/activity has been linked to numerous human disorders, such as cancer. It is now known that miRNAs potentially modulate the production of several metabolic processes in tumor-associated immune cells and indirectly
Identifiants
pubmed: 36483029
doi: 10.3389/fonc.2022.1042196
pmc: PMC9723351
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1042196Informations de copyright
Copyright © 2022 Alshahrani, Ibrahim, Jalil, Altoum, Achmad, Zabibah, Gabr, Ramírez-Coronel, Alameri, Qasim, Karampoor and Mirzaei.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Rev Cancer. 2003 Oct;3(10):721-32
pubmed: 13130303
Oncogene. 2019 Jul;38(28):5551-5565
pubmed: 30967627
Trends Immunol. 2016 Mar;37(3):193-207
pubmed: 26839260
J Immunol. 2018 Oct 1;201(7):2165-2175
pubmed: 30150287
Nucleic Acids Res. 2012 Sep 1;40(17):e135
pubmed: 22645320
Am J Physiol Cell Physiol. 2008 Sep;295(3):C836-43
pubmed: 18650261
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
J Cell Physiol. 2020 Jul;235(7-8):5570-5589
pubmed: 32012265
Biochem Biophys Res Commun. 2014 Feb 7;444(2):270-5
pubmed: 24462768
J Clin Invest. 2012 Aug;122(8):2884-97
pubmed: 22820290
Oncogene. 2010 Jan 21;29(3):313-24
pubmed: 19881548
Oncotarget. 2017 May 2;8(18):30576-30586
pubmed: 28427165
Cell. 2008 Jul 25;134(2):353-64
pubmed: 18662549
Biomolecules. 2022 Apr 14;12(4):
pubmed: 35454171
J Immunol. 2016 Mar 15;196(6):2552-60
pubmed: 26873994
Mol Endocrinol. 2010 Feb;24(2):447-63
pubmed: 20081105
Oncotarget. 2015 Jul 30;6(21):18389-405
pubmed: 26158762
Front Pharmacol. 2017 Jun 30;8:421
pubmed: 28713273
Epigenomics. 2019 Jul;11(9):1021-1036
pubmed: 31184216
Trends Biochem Sci. 2014 Aug;39(8):347-54
pubmed: 25037503
Int J Biochem Cell Biol. 2012 Sep;44(9):1448-56
pubmed: 22634383
Cancer Cell. 2015 Apr 13;27(4):450-61
pubmed: 25858804
Inflammopharmacology. 2018 Jun;26(3):829-838
pubmed: 29052795
Nat Rev Immunol. 2020 Jan;20(1):55-70
pubmed: 31406325
Cells. 2019 Nov 17;8(11):
pubmed: 31744227
Sci Rep. 2016 Feb 23;6:21735
pubmed: 26902416
J Exp Clin Cancer Res. 2016 Oct 3;35(1):160
pubmed: 27716361
EMBO J. 2015 Nov 3;34(21):2671-85
pubmed: 26346275
Oncogene. 2016 May;35(21):2766-76
pubmed: 26477310
Cell Metab. 2016 Jan 12;23(1):27-47
pubmed: 26771115
Front Neurosci. 2015 Feb 27;9:22
pubmed: 25774123
Cell Commun Signal. 2018 Aug 17;16(1):47
pubmed: 30119680
Cell Death Dis. 2020 Dec 14;11(12):1065
pubmed: 33311442
Genes Chromosomes Cancer. 2008 Nov;47(11):939-46
pubmed: 18663744
Am J Physiol Endocrinol Metab. 2014 Feb;306(3):E267-74
pubmed: 24326420
Exp Mol Med. 2013 Oct 04;45:e45
pubmed: 24091747
Genes (Basel). 2022 Jan 29;13(2):
pubmed: 35205318
Trends Endocrinol Metab. 2009 Nov;20(9):452-9
pubmed: 19800254
Cell Mol Life Sci. 2016 Jan;73(2):377-92
pubmed: 26499846
Cancer Biol Med. 2018 May;15(2):103-115
pubmed: 29951335
Nat Rev Immunol. 2018 Jan;18(1):19-34
pubmed: 28944771
Front Oncol. 2019 Nov 01;9:1143
pubmed: 31737570
Oncogenesis. 2017 Jul 10;6(7):e356
pubmed: 28692032
Nature. 2011 Nov 20;481(7381):380-4
pubmed: 22101433
Nat Immunol. 2018 Aug;19(8):838-848
pubmed: 29988091
Front Immunol. 2020 Aug 14;11:1797
pubmed: 32922393
J Immunother Cancer. 2019 Aug 7;7(1):210
pubmed: 31391111
J Immunol. 2014 Jun 1;192(11):5012-22
pubmed: 24760151
Annu Rev Cell Dev Biol. 2011;27:441-64
pubmed: 21985671
Trends Endocrinol Metab. 2013 Jul;24(7):361-73
pubmed: 23602813
Annu Rev Immunol. 2008;26:677-704
pubmed: 18173375
Nat Rev Genet. 2016 Jan;17(1):47-62
pubmed: 26666209
Endocr Rev. 2018 Aug 1;39(4):489-517
pubmed: 29697773
Cell Cycle. 2011 Apr 15;10(8):1271-86
pubmed: 21512313
Cancer Res. 2011 May 1;71(9):3400-9
pubmed: 21389093
Science. 2002 Nov 1;298(5595):1039-43
pubmed: 12351676
Biochem Biophys Res Commun. 2019 Jan 29;509(1):241-248
pubmed: 30591220
Oncol Lett. 2018 Nov;16(5):5946-5952
pubmed: 30344744
Nat Rev Cancer. 2012 Sep;12(9):613-26
pubmed: 22898542
Oncogene. 2016 Jul 14;35(28):3619-25
pubmed: 26592449
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
Nat Commun. 2019 Jul 5;10(1):3000
pubmed: 31278254
Am J Cancer Res. 2017 May 01;7(5):1136-1150
pubmed: 28560062
J Immunol. 2017 Feb 1;198(3):1006-1014
pubmed: 28115590
Immunity. 2013 May 23;38(5):984-97
pubmed: 23623381
Nat Immunol. 2016 Jan;17(1):95-103
pubmed: 26523864
Drug Discov Today. 2017 May;22(5):796-804
pubmed: 27988359
Sci Rep. 2020 Jan 21;10(1):852
pubmed: 31965022
Immunity. 2015 Sep 15;43(3):435-49
pubmed: 26377897
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):264-9
pubmed: 20018759
Cancer Cell. 2010 Mar 16;17(3):225-34
pubmed: 20171147
Cancer Cell. 2017 Nov 13;32(5):669-683.e5
pubmed: 29136509
Oncol Rep. 2017 Mar;37(3):1430-1436
pubmed: 28184935
J Biol Chem. 2014 Mar 14;289(11):7884-96
pubmed: 24492615
Oncol Lett. 2019 May;17(5):4213-4221
pubmed: 30944616
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33555272
Brief Bioinform. 2016 Nov;17(6):996-1008
pubmed: 26655252
Oncol Rep. 2018 Dec;40(6):3533-3542
pubmed: 30272333
Immunity. 2010 Nov 24;33(5):699-712
pubmed: 21093321
Cancer Res. 2018 Sep 15;78(18):5287-5299
pubmed: 30042153
Annu Rev Biomed Eng. 2017 Jun 21;19:163-194
pubmed: 28301735
Cell Metab. 2016 Apr 12;23(4):649-62
pubmed: 27076078
Cell Metab. 2006 Jul;4(1):9-12
pubmed: 16814728
Jpn J Clin Oncol. 2015 Nov;45(11):1055-63
pubmed: 26373319
Immunity. 2013 Dec 12;39(6):1043-56
pubmed: 24315998
Clin Exp Dermatol. 2017 Aug;42(6):614-621
pubmed: 28597996
J Hematol Oncol. 2018 Apr 23;11(1):58
pubmed: 29685162
Cancer Cell Int. 2019 Aug 23;19:219
pubmed: 31462892
Cell Physiol Biochem. 2018;49(2):828-836
pubmed: 30165351
J Clin Invest. 2013 Jul;123(7):2921-34
pubmed: 23921124
PLoS One. 2007 Oct 10;2(10):e1020
pubmed: 17925868
Am J Transl Res. 2018 Feb 15;10(2):483-490
pubmed: 29511442
Nat Commun. 2020 Aug 17;11(1):4111
pubmed: 32807776
Cancer Sci. 2019 Aug;110(8):2368-2377
pubmed: 31222863
Elife. 2017 Jul 24;6:
pubmed: 28737488
Nat Immunol. 2017 Apr 18;18(5):488-498
pubmed: 28418387
EMBO J. 2012 Apr 18;31(8):1985-98
pubmed: 22354042
J Exp Clin Cancer Res. 2020 Jun 17;39(1):114
pubmed: 32552766
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
Immunity. 2016 Feb 16;44(2):380-90
pubmed: 26885860
Semin Cancer Biol. 2008 Oct;18(5):349-55
pubmed: 18467122
Cancer Lett. 2019 Jan;440-441:211-222
pubmed: 30393198
Biochim Biophys Acta. 2009 Aug;1796(1):11-8
pubmed: 19269310
Front Immunol. 2021 May 17;12:657293
pubmed: 34079545
Nature. 2004 Nov 11;432(7014):226-30
pubmed: 15538371
Trends Immunol. 2012 May;33(5):224-30
pubmed: 22361353
J Innate Immun. 2014;6(6):716-26
pubmed: 25138714
Biochem Biophys Res Commun. 2013 Sep 20;439(2):247-51
pubmed: 23973484
Mol Metab. 2020 Apr;34:174-186
pubmed: 32180557
PLoS One. 2013 Oct 23;8(10):e77890
pubmed: 24194900
Int J Mol Sci. 2021 Jan 27;22(3):
pubmed: 33514004
Oncogene. 2013 Feb 7;32(6):797-802
pubmed: 22469988
J Exp Med. 2018 Dec 3;215(12):3165-3179
pubmed: 30429249
J Neurooncol. 2013 Feb;111(3):273-83
pubmed: 23263745
J Hematol Oncol. 2019 Sep 4;12(1):90
pubmed: 31484561
J Immunol. 2015 May 15;194(10):4615-9
pubmed: 25855357
Free Radic Biol Med. 2020 Dec;161:150-162
pubmed: 33059020
Sci Rep. 2018 May 29;8(1):8349
pubmed: 29844352
BMC Cancer. 2014 Jun 16;14:443
pubmed: 24935220
Nat Rev Immunol. 2018 Feb;18(2):81-82
pubmed: 29226911
J Biol Chem. 2012 Jun 29;287(27):23227-35
pubmed: 22593586
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Nat Immunol. 2018 Mar;19(3):213-221
pubmed: 29403049
Cancer Res. 2008 Jul 15;68(14):5540-5
pubmed: 18632605
Int J Mol Sci. 2018 Apr 27;19(5):
pubmed: 29702599
Cancers (Basel). 2021 Nov 24;13(23):
pubmed: 34885023
Hepatology. 2015 Oct;62(4):1132-44
pubmed: 26054020
J Neuroimmunol. 2021 Sep 15;358:577640
pubmed: 34224949
Nat Commun. 2019 Jan 14;10(1):201
pubmed: 30643150
EMBO J. 2015 May 5;34(9):1195-213
pubmed: 25712478
J Immunol. 1994 Mar 15;152(6):2660-8
pubmed: 8144874
Science. 2018 Sep 14;361(6407):
pubmed: 30213884
Nature. 2006 Feb 16;439(7078):871-4
pubmed: 16357870
Exp Cell Res. 2011 Feb 15;317(4):445-51
pubmed: 21087605
Cold Spring Harb Perspect Biol. 2021 Aug 2;13(8):
pubmed: 34341010
J Mol Med (Berl). 2011 Mar;89(3):221-8
pubmed: 21301797
J Immunol. 2010 Jul 1;185(1):605-14
pubmed: 20498354
Biomed Pharmacother. 2022 Apr;148:112760
pubmed: 35228062
Mol Ther. 2018 Feb 7;26(2):568-581
pubmed: 29292163
Oncol Rep. 2015 Jun;33(6):2669-74
pubmed: 25873049
Appl Environ Microbiol. 1983 Mar;45(3):748-54
pubmed: 6682646
Cell Death Dis. 2022 Feb 14;13(2):148
pubmed: 35165280
Cell. 2015 Sep 10;162(6):1217-28
pubmed: 26321681
Curr Opin Lipidol. 2011 Apr;22(2):86-92
pubmed: 21178770
Mol Med. 2021 Apr 1;27(1):34
pubmed: 33794771
J Clin Invest. 2013 Sep;123(9):3678-84
pubmed: 23999442
Radiat Oncol. 2020 Aug 14;15(1):197
pubmed: 32799884
Cancer Lett. 2018 Oct 1;433:10-17
pubmed: 29935373
Cell Biol Int. 2019 Aug;43(8):921-930
pubmed: 31115975
Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):239-50
pubmed: 22436747
Cell Death Dis. 2017 Jul 27;8(7):e2958
pubmed: 28749470
J Pers Med. 2022 Aug 18;12(8):
pubmed: 36013278
PLoS One. 2009;4(5):e5610
pubmed: 19440340
Protein Cell. 2014;5(8):592-602
pubmed: 25015087
Cancer Microenviron. 2011 Aug;4(2):155-62
pubmed: 21909877
Curr Opin Genet Dev. 2010 Feb;20(1):51-6
pubmed: 19942427
Nat Rev Immunol. 2016 Apr 28;16(5):279-94
pubmed: 27121651
Aging Cell. 2012 Jun;11(3):371-7
pubmed: 22321732
Sci Rep. 2017 Jun 8;7(1):3089
pubmed: 28596599
Cell Prolif. 2018 Dec;51(6):e12510
pubmed: 30105813
J Hematol Oncol. 2020 Mar 28;13(1):25
pubmed: 32222150
Nat Metab. 2019 Jan;1:16-33
pubmed: 31032474
Nat Immunol. 2014 Sep;15(9):846-55
pubmed: 25086775
Nat Rev Cancer. 2011 Feb;11(2):85-95
pubmed: 21258394
Immunity. 2017 Sep 19;47(3):406-420
pubmed: 28930657
J Cell Sci. 2005 Dec 1;118(Pt 23):5431-41
pubmed: 16278294
Cell Mol Life Sci. 2022 Mar 29;79(4):216
pubmed: 35348905
Scand J Immunol. 2017 Jun;85(6):395-405
pubmed: 28273403
Nat Rev Cancer. 2020 Sep;20(9):516-531
pubmed: 32632251
Immunity. 2002 Jun;16(6):769-77
pubmed: 12121659
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Oncotarget. 2016 Feb 2;7(5):5972-84
pubmed: 26745603
Cancer Res. 2017 Aug 1;77(15):3965-3981
pubmed: 28701486
Int J Mol Sci. 2016 May 18;17(5):
pubmed: 27213336
Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):
pubmed: 22296764
Oncogene. 2019 Jun;38(26):5158-5173
pubmed: 30872795
Cancer Lett. 2015 Jul 10;363(1):17-27
pubmed: 25818238
Nature. 2016 Apr 14;532(7598):255-8
pubmed: 27049945
Int Immunopharmacol. 2021 Jan;90:107204
pubmed: 33221169
EMBO J. 2000 Aug 1;19(15):3896-904
pubmed: 10921872
PLoS One. 2012;7(12):e50946
pubmed: 23284651
Oncotarget. 2017 Oct 19;8(69):113650-113661
pubmed: 29371936
Nat Rev Immunol. 2016 Sep;16(9):553-65
pubmed: 27396447
Cancer Res. 2010 Jun 15;70(12):5184-93
pubmed: 20501828
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
J Exp Clin Cancer Res. 2019 May 14;38(1):194
pubmed: 31088485
Nat Immunol. 2014 Apr;15(4):323-32
pubmed: 24562310
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4129-34
pubmed: 21325052
Int J Cancer. 2007 Mar 1;120(5):1046-54
pubmed: 17149698
BMC Biol. 2010 Jun 25;8:88
pubmed: 20598111
Mol Ther Oncolytics. 2020 Oct 10;19:218-239
pubmed: 33251334
Nat Rev Drug Discov. 2019 Sep;18(9):669-688
pubmed: 31363227
IEEE/ACM Trans Comput Biol Bioinform. 2022 May-Jun;19(3):1715-1723
pubmed: 33125333
Immunity. 2013 Nov 14;39(5):819-32
pubmed: 24238339
Cancer Biol Med. 2014 Mar;11(1):1-19
pubmed: 24738035
Genes Chromosomes Cancer. 2019 Apr;58(4):244-253
pubmed: 30578699
Sci Rep. 2017 Nov 21;7(1):15897
pubmed: 29162853
Diabetes. 2008 Oct;57(10):2708-17
pubmed: 18591395
FEBS J. 2012 Aug;279(15):2610-23
pubmed: 22621751
IUBMB Life. 2020 Sep;72(9):1856-1869
pubmed: 32516518
EMBO Rep. 2017 Apr;18(4):569-585
pubmed: 28219903
Trends Pharmacol Sci. 2018 Mar;39(3):307-325
pubmed: 29254698
Haematologica. 2021 Jul 01;106(7):1816-1827
pubmed: 31919076
Nat Immunol. 2013 Oct;14(10):1064-72
pubmed: 23955661
Blood. 2013 May 30;121(22):4473-83
pubmed: 23596046
Mol Ther Nucleic Acids. 2016 Aug 30;5(8):e357
pubmed: 27574783
Nature. 2013 Apr 4;496(7443):101-5
pubmed: 23535601
Nat Struct Mol Biol. 2013 May;20(5):541-3
pubmed: 23649362
Cell Metab. 2012 Apr 4;15(4):432-7
pubmed: 22482726
J Nucl Med. 2013 Sep;54(9):1661-7
pubmed: 23886729
JAMA. 2007 May 2;297(17):1901-8
pubmed: 17473300
Cell Metab. 2006 Feb;3(2):87-98
pubmed: 16459310
Cancer Res. 2018 Aug 15;78(16):4586-4598
pubmed: 29880482
Brief Bioinform. 2021 Jan 18;22(1):485-496
pubmed: 31927572
Nature. 2013 Jan 17;493(7432):346-55
pubmed: 23325217
Sci Rep. 2015 Mar 05;5:8801
pubmed: 25739786
Immun Inflamm Dis. 2021 Dec;9(4):1209-1218
pubmed: 34449979
EBioMedicine. 2018 Apr;30:303-316
pubmed: 29463472
Nat Rev Cancer. 2016 Oct;16(10):619-34
pubmed: 27492215
Science. 1956 Aug 10;124(3215):269-70
pubmed: 13351639
Oncotarget. 2017 Jan 10;8(2):2342-2355
pubmed: 27911265
Cell. 2018 Jan 11;172(1-2):22-40
pubmed: 29328913
Cell Metab. 2016 Nov 8;24(5):701-715
pubmed: 27773694
Annu Rev Immunol. 2013;31:259-83
pubmed: 23298210
Cell Metab. 2018 Apr 3;27(4):757-785
pubmed: 29617642
Cell. 2005 Jan 28;120(2):237-48
pubmed: 15680329
Hum Pathol. 2009 Sep;40(9):1234-43
pubmed: 19427019
Nature. 2013 Apr 25;496(7446):445-55
pubmed: 23619691
Cell Death Differ. 2006 May;13(5):816-25
pubmed: 16410796
J Transl Med. 2012 Nov 20;10:228
pubmed: 23164426
Nucleic Acids Res. 2015 Feb 27;43(4):2466-85
pubmed: 25628363
Mol Cell Biol. 2011 Aug;31(15):3182-94
pubmed: 21646425
Cell Rep. 2018 Feb 6;22(6):1509-1521
pubmed: 29425506
Nucleic Acids Res. 2016 Jan 4;44(D1):D1023-31
pubmed: 26590405
Cell. 2015 Jul 30;162(3):552-63
pubmed: 26232225
Future Oncol. 2010 Jan;6(1):127-48
pubmed: 20021214
Cancer Lett. 2018 Jan 28;413:102-109
pubmed: 29111350
Nat Biotechnol. 2014 May;32(5):453-61
pubmed: 24811520
Tumour Biol. 2017 Feb;39(2):1010428317691429
pubmed: 28218035
Immunol Lett. 2021 Apr;232:27-34
pubmed: 33577913
Mol Cancer. 2014 Apr 28;13:92
pubmed: 24775712
Cancer Lett. 2020 Apr 1;474:36-52
pubmed: 31931030
Pathol Res Pract. 2019 Jun;215(6):152383
pubmed: 30890279
Mol Cell Biochem. 2019 Oct;460(1-2):67-79
pubmed: 31218569
Nature. 2009 Apr 9;458(7239):762-5
pubmed: 19219026
Oncogene. 2022 Mar;41(10):1445-1455
pubmed: 35039635
Exp Mol Med. 2020 Sep;52(9):1496-1516
pubmed: 32943735
Front Genet. 2021 Sep 13;12:647152
pubmed: 34589110
Front Cell Infect Microbiol. 2020 Jun 12;10:287
pubmed: 32596169
Mol Cell Pharmacol. 2011;3(3):125-134
pubmed: 22792411
Nat Cell Biol. 2019 May;21(5):542-551
pubmed: 31048766
Gastroenterology. 2015 Nov;149(6):1587-1598.e11
pubmed: 26248089
Free Radic Biol Med. 2012 Aug 1;53(3):421-36
pubmed: 22580150
Immunity. 2011 Dec 23;35(6):871-82
pubmed: 22195744
BMC Cancer. 2012 Jun 12;12:232
pubmed: 22691140
Sci Transl Med. 2011 Jan 26;3(67):67ra8
pubmed: 21270339
Nat Commun. 2019 Apr 2;10(1):1495
pubmed: 30940803
FEBS Lett. 2014 May 2;588(9):1773-9
pubmed: 24685694
Cell Metab. 2010 Oct 6;12(4):352-361
pubmed: 20889127
Sangre (Barc). 1982;27(4-B):727-36
pubmed: 6186038
Oncotarget. 2016 Dec 27;7(52):86103-86116
pubmed: 27861141
J Immunol. 2014 Nov 1;193(9):4477-84
pubmed: 25261477
Front Immunol. 2020 May 15;11:938
pubmed: 32499785